- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT05743153
Gjennomførbarhet av et multimodalt intervensjonsprogram for å optimalisere behandlingsresultater ved ulcerøs kolitt (OPTIMIZE-UC)
OPTIMIZE-UC: Gjennomførbarhet av et multimodalt intervensjonsprogram for å optimalisere behandlingsresultater ved ulcerøs kolitt: en prospektiv pilotstudie
This is a prospective, interventional pilot study to assess the feasibility and optimal timing of a multimodal intervention program in Ulcerative Colitis (UC) patients with active disease as well as in patients in remission. Secondly, to demonstrate the effects of a multimodal intervention program on individual patients level and therapy outcomes.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Rationale: Despite considerable advances in the knowledge of UC, and a variation of treatment options, UC still impacts patients' ability to lead a normal life. Clearly, there is an unmet need to improve treatment outcomes. Prehabilitation programs in surgery have shown that the amount of complications is closely related to preoperative physical fitness, nutritional status and psychological well-being. IBD patients often search for self-management strategies to manage their symptoms, however, research focussing on a multimodal intervention approach in parallel to starting new IBD treatment is lacking. Given the potential benefits of intervention programs, limitations of current treatments in terms of improving quality of life and patients' desire for self-management options, we believe that exploring the results of a multimodal intervention program in patients with UC is of high relevance.
Objective/study design: This is a prospective, interventional pilot study to assess the feasibility and optimal timing of a multimodal intervention program in UC patients. Secondly, to demonstrate the effects of a multimodal intervention program on individual patients level and therapy outcomes.
Study population: Patients ≥ 18 years old, with UC. Intervention: Multimodal intervention program including an exercise program, nutritional intervention and psychological evaluation.
Main study parameters/endpoints: This study assesses the feasibility of a multimodal intervention program. Secondary, assesses the effect on:
- Individual patients' level, i.e. physical fitness, nutritional status, mental health, quality of life and work productivity and activity impairment.
- Therapy outcomes, e.g. adherence, number and severity of (S)AEs, corticosteroid use, biochemical and clinical response/remission rates and patient reported outcomes.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Nijmegen, Nederland, 6525GA
- Dorien Oomkens
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Age ≥ 18 years old;
- Diagnosis of UC confirmed by clinical, endoscopic, and/or histological evidence prior to screening as per standard criteria;
- Ability of subject to participate fully in all aspects of this project;
- Written informed consent must be obtained and documented.
Exclusion Criteria:
- Suspicion of differential diagnosis of CD, indeterminate colitis, ischemic colitis, radiation colitis, diverticular disease associated with colitis, or microscopic colitis;
- Serious underlying disease other than UC that in the opinion of the investigator may interfere with the subject's ability to participate fully in the study or would compromise subject safety (such as history of malignancies, major neurological disorders, certain orthopedic impairments or any unstable, uncontrolled or severe systemic medical disorder);
- History of alcohol or drug abuse that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures;
- History of psychiatric disorders that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures;
- If female, the subject is pregnant or lactating (< 1 year) or intending to become pregnant;
- Immobilized patients who are not able to complete exercise intervention;
- Illiteracy (disability to read and understand Dutch).
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Patients with ulcerative colitis
Patients participate in multimodal intervention |
Exercise intervention: combined endurance and resistance training three times a week using workout video's which patients can do at home. Advice to exercise at low-intensity for at least 30 minutes per day. Nutritional intervention: Patients are advised to aim for optimal energy and protein intake (by registered dietician) and to avoid red meat, processed foods and sweetened drinks. Aiming for a mainly plant based diet. Psychological intervention: screening for psychological risk factors and if present, patients are referred to a psychologist for psychological support. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Accrural
Tidsramme: 24 weeks
|
The percentage of approached, eligible participants that are included in the study. |
24 weeks
|
|
Attrition
Tidsramme: 24 weeks
|
The percentage of participants who stopped the program prematurely. |
24 weeks
|
|
Adherence to exercise program
Tidsramme: 24 weeks
|
Frequency of followed trainings |
24 weeks
|
|
Adherence to daily exercise goals
Tidsramme: 24 weeks
|
SQUASH questionnaire |
24 weeks
|
|
Patient satisfaction
Tidsramme: 24 weeks
|
Measured using a patient satisfaction questionnaire |
24 weeks
|
|
Safety and adverse events
Tidsramme: 24 weeks
|
Measured by the number of adverse events occurring during the program |
24 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Oxygen Consumption (VO2 max)
Tidsramme: 1 year
|
Indication of physical fitness |
1 year
|
|
Change in 1 repitition measures
Tidsramme: 1 year
|
Indication of muscle strength |
1 year
|
|
Change in body weight
Tidsramme: 1 year
|
Measured in kilograms |
1 year
|
|
Change in fat-free mass
Tidsramme: 1 year
|
Measured with bioelectrical impedance analysis (BIA) |
1 year
|
|
Change in nutritional status
Tidsramme: 1 year
|
Measured with Patient Generated Subjective Global Assessment (PG-SGA) |
1 year
|
|
Change in mental health
Tidsramme: 1 year
|
Hospital Anxiety and Depression scale (HADS questionnaire) |
1 year
|
|
Change in Work Productivity and Activity Impairment
Tidsramme: 1 year
|
Work Productivity and Activity Impairment Questionnaire (including WPAI-GH) |
1 year
|
|
Change in 36-Item Short Form Health Survey (SF-36) score
Tidsramme: 1 year
|
Quality of life |
1 year
|
|
Change in EuroQoL (EQ-5D-5L) score
Tidsramme: 1 year
|
Quality of life |
1 year
|
|
Change in Inflammatory Bowel Disease Questionnaire score
Tidsramme: 1 year
|
Disease-related quality of life |
1 year
|
Samarbeidspartnere og etterforskere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 114110
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .